-
Sanofi Pasteur Provides Key Support to the Human Vaccines Project
Sanofi Pasteur is supporting the Project by providing research funding to oversee, coordinate and conduct the scientific and administrative activities of the Human Vaccines Project Research Program this year. The funds will be used by the Project to launch and execute pilot studies, build partnerships with and across the stakeholder community, and set up the infrastructure and operational support for the Human Vaccines Project Research Program, according to Sanofi.
- Categories
- Health Care
- Tags
- vaccines
-
Vaccine Storage Hubs in Six Tribal Districts
The state government is gearing up to strengthen the immunization supply chain in tribal districts to further reduce vaccine preventable infants' deaths.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Brazil Cuts Vaccine Doses as Health System Under Pressure
Brazil has cut the number of doses for vaccinations given by the public health service to counter human papillomavirus (HPV) and pneumonia, as Latin America's largest economy looks to reduce health costs in the midst of a deep recession.
- Categories
- Health Care
- Region
- Latin America
- Tags
- vaccines
-
Cholera Vaccine Supply Set to Double, Easing Global Shortage
Globally, OCV production is low, with demands currently exceeding supply. Sudan and Haiti last year made requests to WHO for supplies of vaccines to conduct pre-emptive vaccination campaigns that could not be filled because of the global shortage.
- Categories
- Health Care
- Tags
- vaccines
-
Gavi, India PM discuss strategic vaccine partnership
Gavi, a global vaccine alliance, proposes to have a new strategic partnership with India for 2016-2021, which will see further fund support of up to $500 million to accelerate the introduction of modern vaccines for all children in the country.
- Categories
- Health Care
- Region
- South Asia
-
Vaccines for Dengue, Malaria in Final Stage
Union Minister for Science and Technology Harsh Vardhan, on Sunday claimed indigenous vaccines against dengue and malaria are in an advanced stage of development.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
The 10 Per Cent Solution
When the cow is in the news mostly for the wrong reasons, an Indian company based in Hyderabad gives us a reason to smile. Indian Immunologicals Ltd (IIL) turns out to be a subsidiary of the National Dairy Development Board. The latter of course was started by the “milkman of India” Verghese Kurien. As Operation Flood, with the aim of turning India into a milk surplus nation, stunned all with its success, the NDDB realised it was spending a fortune on cattle vaccines. In the ’80s, one dose of vaccine cost Rs 14 (equivalent to about Rs 350 today). The NDDB decided to set up IIL, its own vaccine manufacturing subsidiary, in 1982.
- Categories
- Health Care
- Region
- Asia Pacific
- Tags
- vaccines
-
GlaxoSmithKline Partners in Research to Make Vaccines Cheaper for African Babies
Pharmaceutical giant GlaxoSmithKline has partnered with university researchers in Melbourne to develop a new manufacturing method to make vaccines cheaper for families in Africa and elsewhere in the developing world.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa